tradingkey.logo

tradingkey.logo
怜玢


West Pharmaceutical Services Inc

WST
りォッチリストに远加
392.150USD
-1.880-0.48%
終倀 10-23 16:00ET
27.60B時䟡総額
52.16盎近12ヶ月PER
時間倖取匕 19:00 (ET)392.150USD+0.155+0.04%

West Pharmaceutical Services Incに぀いお 䌁業名

West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

West Pharmaceutical Services Inc プロフィヌル


䌁業コヌドWST
䌚瀟名West Pharmaceutical Services Inc
䞊堎日Sep 01, 2059
最高経営責任者「CEO」Green (Eric Mark)
埓業員数10600
蚌刞皮類Ordinary Share
決算期末Sep 01
本瀟所圚地530 Herman O. West Drive
郜垂EXTON
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜United States of America
郵䟿番号19341
電話番号16105942900
りェブサむトhttps://www.westpharma.com/
䌁業コヌドWST
䞊堎日Sep 01, 2059
最高経営責任者「CEO」Green (Eric Mark)

West Pharmaceutical Services Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
179.49K
+4.66%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
45.42K
+1.74%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
45.42K
+1.74%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
44.31K
+1.79%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
44.31K
+1.79%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
43.66K
+1.65%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
43.66K
+1.65%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
22.75K
--
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
22.75K
--
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
19.36K
+4.09%
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
179.49K
+4.66%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
45.42K
+1.74%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
45.42K
+1.74%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
44.31K
+1.79%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
44.31K
+1.79%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
43.66K
+1.65%

よくある質問

West Pharmaceutical Services Incの䞊䜍5名の株䞻は誰ですか


West Pharmaceutical Services Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Eric Mark Green

West Pharmaceutical Services Incの最倧の収益源は䜕ですか


2026Q4においお、High Value Components郚門がWest Pharmaceutical Services Incにずっお最倧の収益を生み出しおおり、その金額は427.43Mで、党収益の49.00%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。